http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006019312-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2b5dbc5a7cd38493108a38fecaa6b1fd http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4b9ae51411466e31bd40e756b970a637 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70539 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
| filingDate | 2005-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7404e3bc714508766ab73d20e9481ae1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16544fa0ac9d3c92f5f718f98136d8f8 |
| publicationDate | 2006-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2006019312-A1 |
| titleOfInvention | CIS-interactions between MHC molecules and co-expressed proteins, related neurological and non-neurological disorders and related therapeutic/diagnostic utilities |
| abstract | The present invention relates to the interactions between MHC Class I molecules and Co-expressed Proteins within the same cell (i.e., cis interaction). These interactions affect overt functional cellular processes by way of influencing protein trafficking and/or signal transduction. For example, in the nervous system, MHC Class I/Co-expressed Protein Interactions can have functional consequences affecting normal brain development, neuronal differentiation, synaptic plasticity and other physiological events. The polymorphic nature of the MHC Class I molecules imparts multiple differences among individuals with regard to the ability of an individual's MHC Class I molecules to interact with specific Co-expressed Proteins and affect cellular function—including the extent to which an individual's inherited MHC Class I haplotypes can affect that individual's specific development, susceptibility to developing diseases and/or their ability to respond to cellular loss, disruption or damage. |
| priorityDate | 2004-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 667.